ISSN: 2329-9096
+44 1300 500008
Department of Pharmacology, Federal University of ParanĂ¡, Curitiba, PR, Brazil
Research Article
Prevalence of Comorbidities in Patients with Psoriasis in Brazil: Preliminary Results of the Pharmacoepidemiological Study Pso.BRA
Author(s): Kauê Cézar Sá Justo, Aguinaldo Bonalumi FIlho, Fernando Henrique Teixeira Zonzini, Jessica Scherer Dagostini, Adriane Reichert Faria, Anber Ancel Tanaka, Daniela Almeida Cabrini, João B Calixto and Michel Fleith Otuki*
Psoriasis is a chronic inflammatory skin disease with multisystem involvement and associated with multiple
comorbidities. It is estimated that the disease affects up to 11.4% of adults. Several factors contribute to the
development and worsening of psoriasis and the identification of these factors is important to individualize therapy
and achieve better therapeutic results and the quality of life for these patients. However, epidemiological data are
scarce, especially in Brazil, making clinical management difficult. The aim of the Pso.BRA study is to trace the
pharmacoepidemiological profile of patients with psoriasis in Brazil. The pilot project included 97 patients over 18
years of age, of both sexes, with psoriasis diagnosed at any level of severity treated at two outpatient psoriasis services
located in Curitiba (Paraná, Brazil). Regarding sociodemogra.. View More»
DOI:
10.35248/2329-9096.22.10.653